Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate
- PMID: 22928077
- PMCID: PMC3427200
- DOI: 10.4161/derm.20514
Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate
Abstract
Evidence continues to mount that vitamin D reduces the risk and mortality rates of many types of disease. However, evidence from prospective cohort studies is sometimes weaker than that from case-control and ecological studies. A suggested reason for this discrepancy is that, because serum levels of 25-hydroxyvitamin D [25(OH)D] change over time, a single 25(OH)D concentration measurement taken at study enrollment does not reliably indicate 25(OH)D concentration related to the health outcome. To evaluate this suggestion further, this paper plots results from 12 prospective cohort studies of all-cause mortality rate vs. follow-up time. The regression fit to the hazard ratio per 20-nmol/l increase in serum 25(OH)D concentration vs. time increased from 0.82 (95% CI, 0.67-1.02) for 6 y to 0.96 (95% CI, 0.90-1.01) for 14 y. The value extrapolated for zero follow-up time was 0.72 (95% CI, 0.50-1.03), giving a hazard ratio reduction 3.5 times higher than the standard result from the meta-analysis [0.92 (95% CI, 0.89-0.95)]. Using the example of the Vitamin D Pooling Project of Rarer Cancers, this paper also discusses follow-up time's effect in interpreting prospective cohort studies of cancer outcome. This paper recommends that meta-analyses of prospective cohort studies account for follow-up time and, if possible, that studies measure serum 25(OH)D concentration every 2-4 y.
Keywords: 25-hydroxyvitamin D; all-cause mortality rate; cancer; case–control studies; ecological studies; prospective cohort studies; ultraviolet-B.
Figures


Similar articles
-
Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22. J Am Geriatr Soc. 2009. PMID: 19549021
-
Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.Am J Clin Nutr. 2013 Apr;97(4):782-93. doi: 10.3945/ajcn.112.047712. Epub 2013 Feb 27. Am J Clin Nutr. 2013. PMID: 23446902
-
Nonlinear Association between Serum 25-Hydroxyvitamin D and All-Cause Mortality in Adults with Inflammatory Bowel Disease in a Prospective Cohort Study.J Nutr. 2022 Sep 6;152(9):2125-2134. doi: 10.1093/jn/nxac148. J Nutr. 2022. PMID: 35816464
-
Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.J Photochem Photobiol B. 2010 Nov 3;101(2):130-6. doi: 10.1016/j.jphotobiol.2010.04.008. Epub 2010 May 12. J Photochem Photobiol B. 2010. PMID: 20570169
-
Serum 25(OH)D Concentration, Vitamin D Supplementation, and Risk of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes or Prediabetes: a Systematic Review and Dose-Response Meta-Analysis.Am J Clin Nutr. 2023 Sep;118(3):697-707. doi: 10.1016/j.ajcnut.2023.07.012. Epub 2023 Jul 18. Am J Clin Nutr. 2023. PMID: 37467897
Cited by
-
Vitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid.Nutr Cancer. 2013;65(6):900-7. doi: 10.1080/01635581.2013.805422. Nutr Cancer. 2013. PMID: 23909735 Free PMC article.
-
Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis.Oncotarget. 2017 Jun 29;8(38):64395-64406. doi: 10.18632/oncotarget.18888. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28969079 Free PMC article.
-
Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium.PLoS One. 2017 Feb 16;12(2):e0170791. doi: 10.1371/journal.pone.0170791. eCollection 2017. PLoS One. 2017. PMID: 28207791 Free PMC article.
-
How Follow-Up Period in Prospective Cohort Studies Affects Relationship Between Baseline Serum 25(OH)D Concentration and Risk of Stroke and Major Cardiovascular Events.Nutrients. 2024 Nov 1;16(21):3759. doi: 10.3390/nu16213759. Nutrients. 2024. PMID: 39519592 Free PMC article. Review.
-
Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D.Nutrients. 2022 Sep 15;14(18):3811. doi: 10.3390/nu14183811. Nutrients. 2022. PMID: 36145186 Free PMC article. Review.
References
-
- IARC Working Group Report 5: Vitamin D and Cancer. IARC, Lyon, France. 2008. - PubMed
LinkOut - more resources
Full Text Sources